Go-TCR: Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells, Increasing Anti-Tumor Efficacy

Author(s):
Hoang, T.P.; Foster, A.; Rodriguez, T.; Torres, D.; Lu, A.; Crisostomo, J.; Jahn, L.; Heemskerk, M.H.M. (0000-0001-6320-9133); Spencer, D.M.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-05-31
Language
English
Is part of
Molecular Therapy (2016), Vol. 24, p. S294-S295
hdl
1887/113856